当前位置: 首页 > 详情页

Identification of a novel anti-heat shock cognate 71 kDa protein antibody in patients with Kawasaki disease

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083 [2]Department of Pediatrics, Beijing Children's Hospital, Capital Medical University, Beijing 100045, P.R. China
出处:
ISSN:

关键词: Antibodies Biomarkers HSP7c Kd

摘要:
Kawasaki disease (Kd) is an idiopathic form of acute systemic vasculitis, which clinically mimics febrile diseases. although it has been hypothesized that immune system malfunction is associated with Kd, its etiology remains unclear. The aim of the present study was to identify a Kd-associated antibody. immunoproteomic methods were used to identify Kd-associated antigens that could be recognized in the sera of patients with Kd. Hela cells were used as an antigen source and Kd sera were used as probe antibodies to determine the binding of the antibodies using an indirect immunofluorescence assay. Western blotting was performed to identify Kd-associated antigens in Hela whole cell lysates. eight out of 12 serum samples obtained from patients with Kd demonstrated immunoreactive bands at ~70 kda, which was later determined to be heat shock cognate 71 kda protein (HSP7c) by mass spectrometry. The diagnostic value of serum anti-HSP7c antibodies for Kd was assessed using eliSa. using a cut-off value of 0.267, anti-HSP7c antibodies were observed to be present in the sera of 60.00% (30/50) of patients with Kd, in 21.05% (8/38) of non-Kd febrile controls, and in 5.26% (2/38) of healthy controls. High serum levels of anti-HSP7c antibodies were detected in the peripheral circulation of patients with Kd. To the best of our knowledge, the present study is the first to observe the high expression levels of anti-HSP7c antibodies in patients with Kd. Therefore, anti-HSP7c antibodies may be used as a diagnostic marker to detect Kd. © 2020 Spandidos Publications. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2018]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083
共同第一作者:
通讯作者:
通讯机构: [1]School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083 [2]Department of Pediatrics, Beijing Children's Hospital, Capital Medical University, Beijing 100045, P.R. China [*1]School of Chemistry and Biological Engineering, University of Science and Technology Beijing, 30 Xueyuan Road, Beijing 100083, P.R. China [*2]Department of Pediatrics, Beijing Children's Hospital, Capital Medical University, 56 Nan Li Shi Road, Beijing 100045, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院